How do executive excess compensation affect enterprise technological innovation : Evidence from a panel threshold model of chinese biopharmaceutical companies
Year of publication: |
2024
|
---|---|
Authors: | Xu, Yong ; Ji, Junzhe ; Li, Nicolas ; Borah, Dhruba |
Published in: |
Journal of business research : JBR. - New York, NY : Elsevier, ISSN 0148-2963, ZDB-ID 2013438-1. - Vol. 179.2024, Art.-No. 114683, p. 1-13
|
Subject: | Chinese Pharmaceutical Industry | Excess Compensation | Innovation Efficiency | Innovation Quality | Technological Innovation | Innovation | China | Pharmaindustrie | Pharmaceutical industry | Innovationsmanagement | Innovation management | Technischer Fortschritt | Technological change |
-
Dhanora, Madan, (2018)
-
Compete or not? : evidence from global biopharmaceutical innovation and market
Zhang, Lili, (2024)
-
Chen, Jinyong, (2021)
- More ...
-
Li, Nicolas, (2023)
-
"Where to" micromultinationals? : a tribute to Professor Pavlos Dimitratos
Ji, Junzhe, (2021)
-
Li, Qinghai, (2024)
- More ...